摘要
目的:探讨宫腔镜术后辅助地屈孕酮治疗,对子宫内膜息肉(EP)患者的临床疗效及预后.方法:选取2019年1月至2022年12月本院收治的82例EP患者作为研究对象.根据治疗方式不同将其分为观察组[n=43,采取宫腔镜下息肉摘除术(TCRP)后联合地屈孕酮片治疗]和对照组(n=39,仅采取TCRP治疗).对比两组治疗效果、子宫内膜变化情况及EP复发率.结果:观察组治疗总有效率显著高于对照组,差异有统计学意义(P<0.05).治疗后,两组患者子宫内膜厚度及月经量,均较其治疗前显著降低,且观察组显著低于对照组,差异均有统计学意义(P<0.05).TCRP后随访至3个月及6个月时,观察组复发率均显著低于对照组,差异均有统计学意义(P<0.05).结论:宫腔镜术后辅助地屈孕酮治疗EP的临床疗效显著,能有效改善患者临床症状,降低复发率,具有良好的临床参考价值.
Objective:To explore the effects of adjuvant dydrogesterone therapy on the clinical efficacy and prognosis of patients with endometrial polyps(EP)after hysteroscopy.Methods:Eighty-two EP patients admitted to our hospital from January 2019 to December 2022 were selected as the research subjects.They were divided into observation group[n=43,tanscervical resection(TCRP)+dydrogesterone tablet treatment]and control group(n=39,TCRP treatment).Compare the treatment effects,endometrial changes,and recurrence rates between two groups.Results:The total effective rate of clinical efficacy in the observation group was higher than that in the control group,the difference was statistically significant(P<0.05).After treatment,endometrial thickness and menstrual flow decreased in the two groups,and the observation group were lower than the control group,the differences were statistically significant(P<0.05).3 months and 6 months after TCRP,the postoperative recurrence rates in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).Conclusion:The clinical efficacy of dydrogesterone in the treatment of EP after hysteroscopy is significant,which can effectively improve the clinical symptoms of patients,and reduce the recurrence rate,and has a good reference value.
作者
李小娟
程芳
崔蔺茹
LI Xiao-juan;CHENG Fang;CUI Lin-ru(Department of Obstetrics and Gynecology,988 Hospital,Chinese People's Liberation Army Joint Logistic Support Force,Jiaozuo 454003,China)
出处
《四川解剖学杂志》
2024年第1期41-43,共3页
Sichuan Journal of Anatomy
关键词
宫腔镜术后
地屈孕酮
子宫内膜息肉
雌激素
临床疗效
预后
After hysteroscopy
Dydrogesterone
Endometrial polyps
Estrogens
Clinical efficacy
Prognosis